Year: 2019
Type: review
Abstract: Diverse but complementary methodologies are required to uncover the complex determinants and pathophysiology of freezing of gait. To develop future therapeutic avenues, we need a deeper understanding of the disseminated functional-anatomic network and its temporally associated dynamic processes. In this targeted review, we will summarize the latest advances across multiple methodological domains including clinical phenomenology, neurogenetics, multimodal neuroimaging, neurophysiology, and neuromodulation. We found that (i) locomotor network vulnerability is established by structural damage, e.g. from neurodegeneration possibly as result from genetic variability, or to variable degree from brain lesions. This leads to an enhanced network susceptibility, where (ii) modulators can both increase or decrease the threshold to express freezing of gait. Consequent to a threshold decrease, (iii) neuronal integration failure of a multilevel brain network will occur and affect one or numerous nodes and projections of the multilevel network. Finally, (iv) an ultimate pathway might encounter failure of effective motor output and give rise to freezing of gait as clinical endpoint. In conclusion, we derive key questions from this review that challenge this pathophysiological view. We suggest that future research on these questions should lead to improved pathophysiological insight and enhanced therapeutic strategies.
Source: Brain
DOI: 10.1093/brain/awz314
Institutions: Hertie Institute for Clinical Brain Research, University of Tübingen, Beth Israel Deaconess Medical Center, Harvard University, Massachusetts General Hospital, Athinoula A. Martinos Center for Biomedical Imaging, University of Michigan, VA Ann Arbor Healthcare System, Michigan Medicine, Emory University, KU Leuven, National Institutes of Health, National Institute of Neurological Disorders and Stroke, The University of Sydney
Language: English
Field: Health Professions
Domain: Health Sciences
Open Access status: bronze
Awards: G1970789506, Modulation of GABA-A Receptors and Axial Motor Impairments in Parkinson Disease, G2834018264, PET Study of Biochemistry and Metabolism of the CNS, Cholinergic mechanisms of attentional-motor integration and gait dysfunction in Parkinson Disease, Emory Clinical Research Site for NEXT, G6722418960, G7544807257, Hyposmia, Cholinergic Denervation and Incipient Cognitive Decline in PD, G8853446690, Using human brain connectivity to identify the causal neuroanatomical substrate of depression symptoms
OpenAlex ID: W2981703144
